Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
Ying‐Ying Lee(Chinese University of Hong Kong), Alfred S.L. Cheng(Chinese University of Hong Kong), Yue S. Cheung(Chinese University of Hong Kong), Joanna H. Tong(Chinese University of Hong Kong), Mingfei Yan(University Hospitals of Cleveland), Qianben Wang(The University of Texas at San Antonio Health Science Center), Ka‐Fai To(Chinese University of Hong Kong), Zhuo Yu(University of North Carolina at Chapel Hill), Myth T.S. Mok(Chinese University of Hong Kong), Kevin Y. Yip(Chinese University of Hong Kong), Wenshu Tang(Chinese University of Hong Kong), Wei Kang(Chinese University of Hong Kong), Grace Lai‐Hung Wong(Chinese University of Hong Kong), Feng Wu(Nantong University), Andrew M. Chan(Chinese University of Hong Kong), Weiqin Yang(Chinese University of Hong Kong), Dae‐Yeul Yu(Korea Research Institute of Bioscience and Biotechnology), Paul B.S. Lai(Chinese University of Hong Kong), Liangliang Xu(Chinese University of Hong Kong), Sau-Dan Lee(Chinese University of Hong Kong)
Cited by 67
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
|Journal of Clinical Oncology|2011|1.6k
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
|Cell|2009|911
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
|Proceedings of the National Academy of Sciences|2015|818